查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1620378

全球鲑鱼降钙素市场：按产品类型、分销管道、地区、范围和预测

Global Calcitonin Salmon Market By Product Type, By Distribution Channel, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

鲑鱼降钙素市场规模及预测

过去几年，鲑鱼降钙素市场规模一直在快速成长，成长率显着，预计该市场在预测期内（即 2024-2031 年）将显着成长。

全球鲑鱼降钙素市场是由全球骨质疏鬆症患者数量不断增加所推动的。根据国际骨质疏鬆基金会统计，全球每年有超过 890 万人患有骨质疏鬆症。全球鲑鱼降钙素市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球鲑鱼降钙素市场定义

降钙素，也称为甲状腺降钙素，是一种由人类甲状腺滤泡旁细胞产生的线性多□激素。在鸟类、鱼类和其他非哺乳动物中，降钙素是由胰管中的细胞产生的。降钙素降低血液中钙和磷酸盐的浓度，促进骨形成。降钙素抑制称为破骨细胞的去骨细胞，同时促进称为成骨细胞的骨形成细胞。与哺乳动物来源的降钙素相比，每毫克鲑鱼降钙素的效力更大，作用持续时间更长。

鲑鱼降钙素是利用重组DNA技术透过合成方法或微生物方法生产的。鲑鱼降钙素有两种剂型：注射剂和鼻喷剂。 Fortical 和密钙星是鲑鱼降钙素的常见品牌。鲑鱼降钙素用于治疗骨质疏鬆症、高血钙症、佩吉特骨病变和其他骨骼相关疾病。

鲑鱼降钙素的世界市场概况

全球鲑鱼降钙素市场是由全球骨质疏鬆症患者数量不断增加所推动的。根据国际骨质疏鬆基金会统计，全球每年有超过 890 万人患有骨质疏鬆症。骨质疏鬆症在女性中比男性更常见，并且在老年族群中更常见。根据国际骨质疏鬆基金会的研究，全球有超过2亿名女性受到骨质疏鬆症的影响。 FDA 咨询委员会建议不要使用鲑鱼降钙素来治疗女性经后骨质疏鬆症，因为有罹患癌症的风险。

此外，鲑鱼降钙素也被用作骨质疏鬆症的二线治疗药物。鲑鱼降钙素的副作用可能是全球市场的主要阻碍因素。此外，佩吉特氏症并不是一种常见疾病。这些因素阻碍了鲑鱼降钙素市场的成长。作为骨质疏鬆症和相关疾病一线治疗药物的其他药物的现成供应可能会限制市场。 FDA 咨询委员会建议开发新鲑鱼降钙素产品的公司证明其在减少骨折方面的有效性。预计将提振市场。

世界人口老化是骨质疏鬆症发生率上升的主要原因。骨质疏鬆症因其在世界范围内的高盛行率而被报告为一个严重的公共卫生问题。据估计，目前全球有超过2亿人患有骨质疏鬆症。此外，随着鲑鱼降钙素被批准作为停经后患者的预防和其他治疗药物，预计未来需求将会增加。农村地区对骨质疏鬆症和其他骨骼疾病缺乏认识阻碍了鲑鱼降钙素市场的成长。

此外，长期使用的副作用正在阻碍鲑鱼降钙素市场的成长。人类使用药物委员会建议，鲑鱼降钙素应服用两週，最多四週，以预防因突然不动而造成的急性骨质流失。

目录

第一章全球鲑鱼降钙素市场介绍

  • 市场概览
  • 调查范围
  • 先决条件

第 2 章执行摘要

第三章验证市场研究研究方法

  • 资料探勘
  • 验证
  • 初步面试
  • 资料来源列表

第四章世界鲑鱼降钙素市场前景

  • 摘要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力模型
  • 价值链分析

第五章全球鲑鱼降钙素市场：依产品类型

  • 摘要
  • 鲑鱼降钙素鼻喷剂
  • 鲑鱼降钙素注射液

第 6 章鲑鱼降钙素的全球市场：依通路划分

  • 摘要
  • 医院药房
  • 零售药局
  • 网路药局

第 7 章鲑鱼降钙素的全球市场：按地区划分

  • 摘要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东

第八章全球鲑鱼降钙素市场竞争格局

  • 摘要
  • 各公司的市场排名
  • 主要发展策略

第九章公司简介

  • Novartis
  • Sanofi
  • Mylan Pharmaceuticals
  • Apotex
  • Upsher-Smith Laboratories
  • Ferring Pharmaceuticals
  • Par Pharmaceutical
  • Torrent
  • Sun Pharmaceutical
  • Shanghai Soho-Yiming Pharmaceuticals

第 10 章附录

  • 相关研究
简介目录
Product Code: 11842

Calcitonin Salmon Market Size And Forecast

Calcitonin Salmon Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2024 to 2031.

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. The Global Calcitonin Salmon Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Calcitonin Salmon Market Definition

Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In birds, fish, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg is greater and has longer duration of action than calcitonin produced by mammalian origin.

Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Fortical and Miacalcin are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Calcitonin Salmon Market Overview

The global Calcitonin Salmon Market is driven by rising number of osteoporosis patients globally. According to the International Osteoporosis Foundation, over 8.9 million people suffer from osteoporosis globally each year. Osteoporosis is more dominant in women than men and is common in geriatric population. The International Osteoporosis Foundation study reveals that over 200 million women are affected by osteoporosis globally. The FDA advisory committee has recommended preventing use of calcitonin salmon for the treatment of postmenstrual osteoporosis in women as there exists a potential risk of cancer development.

Moreover, calcitonin salmon is used as second line of treatment for osteoporosis. Side effects of calcitonin salmon are likely to be key restraints of the global market. Large number of people is not aware about having osteoporosis until they have first fracture and also Paget's disease is not common in people. These factors hamper the growth of the Calcitonin Salmon Market. Easy availability of other medications for the first line treatment of osteoporosis and related diseases is likely to restrain the market. The FDA advisory committee has suggested to companies developing new calcitonin salmon products to prove its effectiveness in reducing bone fractures. This is expected to boost the market.

Aging of populations worldwide is the major reason for the rise in the incidence of osteoporosis. Osteoporosis is reported as a serious public health concern, owing to its high prevalence worldwide. At present, it is estimated that over 200 million people globally suffer from osteoporosis. In addition, calcitonin salmon's approval for the prevention of postmenopausal and other treatment to uplift the demand in growth in the future. Lack of awareness in rural areas about osteoporosis and other bone disorder is hindering the growth of Calcitonin Salmon Market.

Furthermore, adverse effects caused due to prolong use are hampering the growth of the Calcitonin Salmon Market. It has been found that prolonged use rises the risk for cancer, attributed to this Committee for Medicinal Products for Human Use recommended that calcitonin salmon should be prescribed for two weeks with a maximum duration of four weeks for prevention of acute bone loss due to sudden immobilization.

Global Calcitonin Salmon Market Segmentation Analysis

The Global Calcitonin Salmon Market is Segmented On The Basis Of Product Type, Distribution Channel, and Geography.

Calcitonin Salmon Market, By Product Type

  • Calcitonin Salmon Nasal Spray
  • Calcitonin Salmon Injection

Based on Product Type, the market is segmented into Calcitonin Salmon Nasal Spray, Calcitonin Salmon Injection. Calcitonin salmon is produced either by synthetic processes or by microbial processes using recombinant DNA technology. Calcitonin salmon is available in two forms: injection and nasal. Miacalcin and Fortical are commonly available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases.

Calcitonin Salmon Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on Distribution Channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts.

Calcitonin Salmon Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, the Global Calcitonin Salmon Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Prevalence of osteoporosis is higher in Middle East & Africa than in countries in the West. This is expected to propel the Calcitonin Salmon Market in this region. Increasing geriatric population with bone related diseases is likely to fuel the growth of the market in Asia Pacific during the forecast period.

  • Key Players In Calcitonin Salmon Market
  • The "Global Calcitonin Salmon Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
  • Novartis, Sanofi, Mylan Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Ferring Pharmaceuticals, Par Pharmaceutical, Torrent, Sun Pharmaceutical, United Biotech (P) Limited. and Shanghai Soho-Yiming Pharmaceuticals.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • Global Calcitonin Salmon Market

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CALCITONIN SALMON MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CALCITONIN SALMON MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CALCITONIN SALMON MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Calcitonin Salmon Nasal Spray
  • 5.3 Calcitonin Salmon Injection

6 GLOBAL CALCITONIN SALMON MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
  • 6.2 Hospital Pharmacies
  • 6.3 Retail Pharmacies
  • 6.4 Online Pharmacies

7 GLOBAL CALCITONIN SALMON MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East

8 GLOBAL CALCITONIN SALMON MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Novartis
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Sanofi
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Mylan Pharmaceuticals
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Apotex
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Upsher-Smith Laboratories
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Ferring Pharmaceuticals
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Par Pharmaceutical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Torrent
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sun Pharmaceutical
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Shanghai Soho-Yiming Pharmaceuticals
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research